Esquizofrenia, abuso de substâncias e imigração

Autores

DOI:

https://doi.org/10.25118/2763-9037.2013.v3.358

Resumo

.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Wobrock T, Soyka M. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1375-85. DOI: https://doi.org/10.1016/j.pnpbp.2008.02.008

Green AI, Noordsy DL, Brunette MF, O’Keefe C. Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat. 2008;34:61-71. Epub 2007 Jun 15. DOI: https://doi.org/10.1016/j.jsat.2007.01.008

Laqueille X, Launay C, Kanit M. [Induced psychiatric and somatic disorders to cannabis] Ann Pharm Fr. 2008;66:245-54. Epub 2008 Sep 4. DOI: https://doi.org/10.1016/j.pharma.2008.06.001

Coulston CM, Perdices M, Tennant CC. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust N Z J Psychiatry. 2007;4:869-84. DOI: https://doi.org/10.1080/00048670701634952

Green AI. Schizophrenia and comorbid substance use disorder: effects of antipsychotics. J Clin Psychiatry. 2005; 66: 21-6.

Cantor-Graae E. The contribution of social factors to the development of schizophrenia: a review of recent findings. Can J Psychiatry. 2007; 52:277-86. DOI: https://doi.org/10.1177/070674370705200502

Palomo T, Archer T, Kostrzewa RM, Beninger RJ. Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res. 2007;12:17-27. DOI: https://doi.org/10.1007/BF03033898

Le Bec PY, Fatséas M, Denis C, Lavie E, Auriacombe M. [Cannabis and psychosis: search of a causal link through a critical and systematic review] Encephale. 2009;35:77-85. Epub 2008 Jul 9. DOI: https://doi.org/10.1016/j.encep.2008.02.012

DeLisi LE. The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry. 2008:21:140-50. DOI: https://doi.org/10.1097/YCO.0b013e3282f51266

Wobrock T, Soyka M. Pharmacotherapy of patients with schizophrenia and substance abuse. Expert Opin Pharmacother. 2009;10:353-67. 11. Realini N, Rubino T, Parolaro D. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacol Res. 2009;60:132-8. Epub 2009 Mar 17 DOI: https://doi.org/10.1016/j.phrs.2009.03.006

Cantor-Graae E, Selten JP. Schizophrenia andmigration: a meta-analysis and review. Am J Psychiatry. 2005:162:12-24 DOI: https://doi.org/10.1176/appi.ajp.162.1.12

Selten JP, Cantor-Graae E, Kahn RS. Migration and schizophrenia. Curr Opin Psychiatry. 2007;20:111-5 DOI: https://doi.org/10.1097/YCO.0b013e328017f68e

Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry. 2012: 25:194-200. DOI: https://doi.org/10.1097/YCO.0b013e328351a3e0

Downloads

Publicado

2013-06-30

Como Citar

1.
Meleiro AMA da S. Esquizofrenia, abuso de substâncias e imigração. Debates em Psiquiatria [Internet]. 30º de junho de 2013 [citado 5º de fevereiro de 2025];3(3):40-3. Disponível em: https://revistardp.org.br/revista/article/view/358

Edição

v. 3 n. 3 (2013)

Seção

Relato de Caso

Licença

Creative Commons License

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.

Debates em Psiquiatria permite que o (s) autor (es) mantenha(m) seus direitos autorais sem restrições. Atribuição-NãoComercial 4.0 Internacional (CC BY-NC 4.0) - Debates em Psiquiatria é regida pela licença CC-BY-NC

Crossref
Scopus
Google Scholar
Europe PMC

Plaudit

Artigos mais lidos do(s) mesmo(s) autor(es)